학술논문
NRG/RTOG 1112: Randomized Phase III Study of Sorafenib vs. Stereotactic Body Radiation Therapy (SBRT) Followed by Sorafenib in Hepatocellular Carcinoma (HCC) (NCT01730937)
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 December 2022 114(5):1057-1057
Subject
Language
ISSN
0360-3016